= Additional active ingredients
Epinastine HCl 0.5 mg/ml (eq. to 0.436 mg epinastine).
PRESENTATION AND DOSSAGE
Treatment of the symptoms of seasonal allergic conjunctivitis.
Hypersensitivity to epinastine or to any excipient.
Patients should be instructed to wait 10-15 minutes after instillation and before inserting contact lenses. Should not be administered while wearing lenses. Pregnancy and lactation: Caution should be exercised when prescribing to pregnant or lactating women.
No serious side effects have been reported. Most were ocular and mild, the most common being a mostly mild burning sensation in the eye.
MANUFACTURER & DISTRIBUTER:
License Holder: Allergan Israel Ltd.